Original Source: Journal of Clinical Psychiatry, all rights reserved. —
Background: Neurosteroids, such as pregnenolone, have potential in mood disorder treatment. Because depression is associated with dysregulated connectivity in brain networks, a systems-level biomarker for neurosteroids modulation of large-scale brain networks can offer critical insight into circuits underlying treatment response. To our knowledge, no studies have examined resting-state functional connectivity (rsFC) in people with depression following pregnenolone administration.
Methods: In this crossover design study conducted between 2019–2021, women (n=29, mean age=45.6 years) with major depressive disorder (DSM-5) were randomized to 7 days of oral pregnenolone 500 mg/d, pregnenolone 800 mg/d, and placebo with a 14-day washout between conditions. After each treatment, steroid levels and resting-state fMRI (rsfMRI) data were collected. A seed-based voxel-wise analysis, with bilateral amygdala as seed, investigated rsFC alterations following treatment conditions in a per-protocol sample (n=11).
Results: Compared to placebo, pregnenolone 500 mg/d was associated with decreased connectivity between the bilateral amygdala and left frontal pole (PFDR=.011). Difference in amygdala connectivity between pregnenolone 800 mg/d and placebo was nonsignificant. Allopregnanolone serum levels increased significantly with administration of either pregnenolone dose as compared to placebo.
Conclusions: Findings suggest that pregnenolone 500 mg/d was associated with decreased connectivity between the amygdala and frontal pole, brain regions pertinent to depression and cognitive control. Presence of rsFC changes at 500 mg/d but not 800 mg/d suggests an inverted-U dose–response pattern, where moderate dosing optimally engages neural circuits compared to higher doses.
Trial Registration: ClinicalTrials.gov identifier: NCT03645096 J Clin Psychiatry 2026;87(4):26m16360 Author affiliations are listed at the end of this article.
Read the full article at Psychiatrist.com
Journal of Clinical Psychiatry, all rights reserved.